In the News

Share
445 News Items found
To our Community
A Message From Dr. Selwyn Vickers, MSK’s President and CEO
Learn about immunotherapy advances for cancer treatment from Dr. Selwyn Vickers, President and CEO of Memorial Sloan Kettering.
Microscopy image showing a quiescent cluster of lung adenocarcinoma tumor cells with low STING expression.
MSK Scientists Identify Potential New Strategy Against Metastasis
A team of scientists at the Sloan Kettering Institute has identified the STING cellular signaling pathway as a key player in keeping dormant cancer cells from progressing into aggressive tumors months, or even years, after they’ve escaped from a primary tumor.
Nadeem Riaz (left) and Jorge Reis-Filho (right)
For People with Certain BRCA Mutations, Activating the Immune System Could Be Promising Treatment
Human data and results from mouse experiments suggest that people with BRCA2 mutations may respond well to immunotherapy drugs.
Karen Granville
Karen Granville Believes in Paying it Forward for Women’s History Month
Karen Granville works as a patient advocate to increase their access to MSK for cancer treatment.
Memorial Sloan Kettering researchers Luc Morris and Nils Weinhold
Machine Learning Approach Takes MSK Researchers Beyond Known Method to Predict Immunotherapy Response
Learn about recent research led by MSK physician-scientist Luc Morris, who is trying to better predict who will benefit from immunotherapy.
Philipp Niethammer
Playing with Fire: Fish, Ferroptosis, and the Combustible Chemistry of Wound Detection
Cell biologists are finding surprising overlaps between a particular form of programmed cell death and the process of wound detection.
Announcement
Eleven Scientists Join World-Renowned Faculty at Gerstner Sloan Kettering
Meet the 11 new faculty members that have joined the Gerstner Sloan Kettering (GSK) Graduate School of Biomedical Sciences.
Feature
Rihanna sitting in a chair outside
Getting to the Root of Pediatric Cancers
MSK Kids is leading a major effort to fully deliver on the promise of precision medicine for our youngest patients.
Dr. Teddy Yewdell presenting at the MSK Postdoc Slam and in front of the sign of his new employer, Genentech.
Training the Next Generation of Scientists: Meet 3 Remarkable MSK Alumni
At MSK, our goal is not just to train the scientists of tomorrow, but the scientific leaders.
Finding
Scientists Jan Remsik, Adrienne Boire, and Jessica Wilcox in the lab
MSK Researchers Learn What’s Driving ‘Brain Fog’ in People with COVID-19
The presence of inflammatory molecules in the cerebrospinal fluid appears to be causing many of the neurologic effects seen in people with COVID-19.